BRAF and melanoma: Notably, MCP-1, also considered as autocrine growth factor for melanoma and a metastasis-inducer, is produced by BRAF-resistant melanoma cells, and its plasma level was shown to increase in melanoma patients during BRAFi treatments [42,43].